Project 3 – Dr. Jefferson Kinney

<h3>The Role of GABA in Microglial Activation and Neurodegeneration in Alzheimer's Disease</h3>

Jefferson W. Kinney, Ph.D.

<iframe width="1280" height="720" src="https://www.youtube.com/embed/H1GWCxz0FLs?rel=0" frameborder="0" gesture="media" allow="encrypted-media" allowfullscreen></iframe>

Specific Aims:

  1. Examination of GABA and immune alterations in a mouse model of AD.
              
  2. Cross CX3CR1-CRE-ER mice with GABAB(1)lox511/lox511 mice to allow an inducible knockout of GABAB receptors specific to microglia.
              
  3. Determine if removal of GABABR on microglia exacerbate behavioral or pathological markers of AD in each of the groups tested in SA2 (WT, 3xTg-AD, GABABR microglial KO, 3xTg-AD + GABABR microglial KO).

Personnel:

  • Dr. Arnold Salazar
  • Andrew Murtishaw
  • Austin Boren
  • Amanda Leisigang

Internal Mentor

Martin Schiller, Ph.D.
Professor at UNLV
Director, Nevada Institute for Personalized Medicine
(Mentor: Project 3)